Citadel Advisors’s iShares LifePath Target Date 2065 ETF ITDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Buy
16,599
+6,295
+61% +$257K ﹤0.01% 9082
2026
Q1
$381K Buy
+10,304
New +$396K ﹤0.01% 9915
2025
Q4
Sell
-6,008
Closed -$223K 13362
2025
Q3
$223K Sell
6,008
-1,879
-24% -$66.9K ﹤0.01% 11038
2025
Q2
$272K Sell
7,887
-1,234
-14% -$39.4K ﹤0.01% 10022
2025
Q1
$283K Buy
+9,121
New +$291K ﹤0.01% 9734
2024
Q3
Sell
-15,076
Closed -$454K 14728
2024
Q2
$454K Buy
+15,076
New +$443K ﹤0.01% 8255
2024
Q1
Sell
-25,577
Closed -$699K 15018
2023
Q4
$699K Buy
+25,577
New +$660K ﹤0.01% 7404

Other funds holding ITDI

Citadel Advisors's ITDI Position: Q2 2026 in Review

Citadel Advisors increased its iShares LifePath Target Date 2065 ETF (ITDI) stake by 61% in Q2 2026, buying an estimated $257K and bringing the position to 16,599 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #9082.

Citadel Advisors first reported a position in ITDI in Q4 2023 and has held it in 7 quarters since. 6 funds tracked by Wall St. Rank hold ITDI as of Q2 2026.

  • Citadel Advisors held 16,599 shares of iShares LifePath Target Date 2065 ETF worth $700K as of Q2 2026.
  • Citadel Advisors bought 6,295 iShares LifePath Target Date 2065 ETF shares in Q2 2026, an estimated $257K.
  • iShares LifePath Target Date 2065 ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9082 holding.
  • Citadel Advisors first reported a position in iShares LifePath Target Date 2065 ETF in Q4 2023 and has held it in 7 quarters since.
  • 6 funds tracked by Wall St. Rank held iShares LifePath Target Date 2065 ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.